LabCorp to Announce Fourth Quarter and Full Year 2019 Financial Results on February 13, 2020

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 13, 2020-- LabCorp® (NYSE: LH) will release its fourth quarter and full year 2019 financial results before the market opens on Thursday, Feb. 13, 2020 , and then will host a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results.

Labcorp and Covance launch extensive preclinical, clinical and post-approval cell and gene therapy development solutions

Specialized Expertise, Coordinated Capabilities and Targeted Investments Designed to Accelerate Development and Reduce Risk for Sponsors BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 13, 2020-- Labcorp® (NYSE:LH), a leading global life sciences company that is deeply integrated in guiding patient care,

LabCorp is Scheduled to Present at the 38th Annual J.P. Morgan Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 6, 2020-- LabCorp® (NYSE: LH) today announced that members of the executive management team will participate in a fireside chat at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, Jan. 14 at 1:30 p.m. (PT) .

Concentration of branched-chain amino acids is a strong risk marker for incident hypertension